InDevR Collaborating with Scientists at St. Jude Children’s Research Hospital to Evaluate FluChip-8G
BOULDER, Colorado – (August 25, 2015) – InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced today that the lab of Richard Webby, Ph.D., at St. Jude Children’s Research Hospital (St. Jude) will be aiding in the development of a new influenza diagnostic, including evaluating assay performance on non-seasonal influenza viruses. The FluChip-8G in vitro diagnostic device is currently in advanced development supported by the Biomedical Advanced Research and Development Authority (BARDA, HHSO100201400010C).
Webby is an influenza expert and director of the World Health Organization Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds at St. Jude. His team will evaluate the performance of the FluChip-8G assay with unique non-seasonal influenza viruses and provide feedback to InDevR. According to Dr. Erica Dawson, VP of Research and Development at InDevR, “It is critical to put this assay in the hands of other scientists to better understand how the technology will perform in the field.”
Once cleared by the U.S. Food and Drug Administration, FluChip-8G is expected to enhance clinical diagnosis of influenza by enabling physicians to rapidly distinguish between seasonal and potential pandemic non-seasonal influenza viruses, such as H5N1 or H7N9.
InDevR has a demonstrated commitment to innovative solutions for the clinical and life science industries. With focus on enhancing diagnostics as well as vaccines and other biotherapeutics, InDevR has emerged as a leader in progressive new analytical technologies that enable accelerated development and manufacturing of these life-saving products. For more information about the company and products, please visit www.indevr.com or call 303-402-9100.
HHS and St. Jude Children’s Research Hospital, Inc. are not responsible for the contents of this release. The statements contained in this release do not constitute endorsement or recommendation by the U.S. Government, HHS, St. Jude Children’s Research Hospital, Inc. or Richard Webby, Ph.D.